ICD-10: E08.33

Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy

Additional Information

Description

Diabetes mellitus due to an underlying condition, specifically coded as E08.33, is a classification within the International Classification of Diseases, 10th Revision (ICD-10). This code is used to identify cases of diabetes that arise as a consequence of another medical condition, and it specifically denotes the presence of moderate nonproliferative diabetic retinopathy (NPDR).

Clinical Description

Diabetes Mellitus Due to Underlying Condition

The E08 code series is designated for diabetes mellitus that is secondary to another condition, such as endocrine disorders, pancreatic diseases, or other systemic illnesses. In the case of E08.33, the diabetes is linked to an underlying condition that has led to the development of diabetic retinopathy, a common complication of diabetes affecting the eyes.

Moderate Nonproliferative Diabetic Retinopathy

Moderate NPDR is characterized by specific retinal changes that can be observed during an eye examination. These changes include:

  • Microaneurysms: Small bulges in the blood vessels of the retina.
  • Retinal Hemorrhages: Small areas of bleeding within the retina.
  • Exudates: Deposits of lipids and proteins that can appear as cotton wool spots or hard exudates.

In moderate NPDR, these changes are more pronounced than in mild NPDR but do not yet include the more severe complications associated with proliferative diabetic retinopathy, such as neovascularization (the growth of new blood vessels) or significant vision loss.

Clinical Implications

Diagnosis and Management

Patients diagnosed with E08.33 require careful monitoring and management of both their diabetes and the associated retinopathy. Management strategies may include:

  • Blood Glucose Control: Tight glycemic control is essential to prevent further progression of diabetic retinopathy.
  • Regular Eye Examinations: Patients should undergo regular dilated eye exams to monitor the status of their retinopathy and detect any progression early.
  • Treatment Options: Depending on the severity and progression of retinopathy, treatment options may include laser therapy or intravitreal injections if the condition worsens.

Underlying Conditions

The underlying conditions that can lead to E08.33 may vary widely, including but not limited to:

  • Chronic Pancreatitis: Inflammation of the pancreas that can impair insulin production.
  • Cushing's Syndrome: A hormonal disorder caused by high levels of cortisol, which can lead to insulin resistance.
  • Genetic Disorders: Certain genetic conditions can predispose individuals to diabetes.

Conclusion

ICD-10 code E08.33 is crucial for accurately documenting and managing diabetes mellitus that arises due to an underlying condition, particularly when accompanied by moderate nonproliferative diabetic retinopathy. Proper coding ensures that patients receive appropriate care and monitoring, which is vital for preventing complications and maintaining quality of life. Regular follow-ups and a comprehensive treatment plan are essential for managing both the diabetes and its ocular complications effectively.

Clinical Information

Diabetes mellitus due to an underlying condition, classified under ICD-10 code E08.33, is a specific diagnosis that encompasses a range of clinical presentations, signs, symptoms, and patient characteristics. This condition is particularly associated with moderate nonproliferative diabetic retinopathy (NPDR), which is a common complication of diabetes. Below is a detailed overview of the clinical aspects related to this diagnosis.

Clinical Presentation

Overview of Diabetes Mellitus

Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. In the case of E08.33, the diabetes is secondary to another underlying condition, which could include diseases such as pancreatitis, cystic fibrosis, or hormonal disorders that affect insulin production or action[1].

Nonproliferative Diabetic Retinopathy

Moderate nonproliferative diabetic retinopathy is a stage of diabetic eye disease where changes in the retina occur due to prolonged high blood sugar levels. This stage is characterized by the presence of microaneurysms, retinal hemorrhages, and exudates, but without the growth of new blood vessels (neovascularization) that characterizes proliferative diabetic retinopathy[2].

Signs and Symptoms

General Symptoms of Diabetes

Patients with diabetes mellitus may present with a variety of symptoms, including:
- Polyuria: Increased urination due to osmotic diuresis from high blood glucose levels.
- Polydipsia: Increased thirst as a compensatory mechanism for fluid loss.
- Polyphagia: Increased hunger due to the body’s inability to utilize glucose effectively.
- Fatigue: Generalized tiredness resulting from metabolic imbalances.
- Blurred Vision: Often a result of fluctuating blood glucose levels affecting the lens of the eye[3].

Specific Symptoms of Moderate Nonproliferative Diabetic Retinopathy

Patients with moderate NPDR may experience:
- Visual Disturbances: Blurred or fluctuating vision, which can be intermittent and may worsen over time.
- Scotomas: Blind spots in the visual field due to localized retinal damage.
- Difficulty with Color Vision: Changes in the ability to perceive colors accurately, particularly in low-light conditions[4].

Patient Characteristics

Demographics

  • Age: Typically, patients diagnosed with diabetes mellitus and its complications are often middle-aged or older, although the prevalence in younger populations is increasing due to rising obesity rates and sedentary lifestyles.
  • Gender: Both males and females are affected, but some studies suggest a slightly higher prevalence in males for certain types of diabetes[5].

Risk Factors

  • Underlying Conditions: The presence of conditions such as pancreatitis, hormonal disorders, or genetic syndromes can predispose individuals to develop diabetes mellitus due to underlying conditions.
  • Duration of Diabetes: Longer duration of diabetes is associated with a higher risk of developing diabetic retinopathy.
  • Poor Glycemic Control: Elevated HbA1c levels are strongly correlated with the development and progression of diabetic retinopathy[6].
  • Hypertension and Dyslipidemia: Coexisting conditions such as high blood pressure and abnormal lipid levels can exacerbate the risk of retinopathy[7].

Comorbidities

Patients with E08.33 may also present with other complications of diabetes, including:
- Neuropathy: Nerve damage leading to pain, tingling, or loss of sensation, particularly in the extremities.
- Nephropathy: Kidney damage that can progress to chronic kidney disease.
- Cardiovascular Disease: Increased risk of heart disease and stroke due to the effects of diabetes on vascular health[8].

Conclusion

ICD-10 code E08.33 represents a significant clinical condition where diabetes mellitus is secondary to an underlying disease, accompanied by moderate nonproliferative diabetic retinopathy. Understanding the clinical presentation, signs, symptoms, and patient characteristics is crucial for effective management and intervention. Regular monitoring and comprehensive care are essential to mitigate the risks of complications associated with this condition, emphasizing the importance of glycemic control and routine eye examinations for early detection and treatment of retinopathy.

Approximate Synonyms

Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy is classified under the ICD-10 code E08.33. This specific code is part of a broader classification system used for diagnosing and coding various health conditions. Below are alternative names and related terms associated with this code.

Alternative Names

  1. Diabetes Mellitus Secondary to Other Conditions: This term emphasizes that the diabetes is a result of another underlying health issue, distinguishing it from primary diabetes types.

  2. Diabetes Due to Underlying Disease: This phrase highlights the causative relationship between the diabetes and the underlying condition.

  3. Moderate Nonproliferative Diabetic Retinopathy: This term specifically refers to the eye condition associated with diabetes, indicating the severity of the retinopathy.

  4. E08.33 Diabetes with Moderate Nonproliferative Retinopathy: A shorthand version that combines the ICD-10 code with the condition description.

  1. Diabetic Retinopathy: A common complication of diabetes that affects the eyes, which can be classified into nonproliferative and proliferative stages.

  2. Nonproliferative Diabetic Retinopathy (NPDR): This is a stage of diabetic retinopathy where there is no growth of new blood vessels, but there are changes in the retina that can lead to vision problems.

  3. Moderate NPDR: A specific classification within nonproliferative diabetic retinopathy, indicating a certain level of severity.

  4. Secondary Diabetes: A broader term that encompasses diabetes resulting from other medical conditions, including those leading to E08.33.

  5. ICD-10 Code E08: The broader category under which E08.33 falls, encompassing all diabetes mellitus due to underlying conditions.

  6. Diabetes Mellitus: A general term for a group of diseases that affect how the body uses blood sugar (glucose), which includes various types such as Type 1, Type 2, and gestational diabetes.

  7. Chronic Complications of Diabetes: This term refers to long-term complications that can arise from diabetes, including retinopathy, neuropathy, and nephropathy.

Understanding these alternative names and related terms can help in accurately diagnosing and coding for diabetes mellitus due to underlying conditions, particularly in clinical and billing contexts. This specificity is crucial for effective patient management and healthcare documentation.

Diagnostic Criteria

The diagnosis of ICD-10 code E08.33, which refers to "Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy," involves specific criteria that align with both the classification of diabetes and the assessment of diabetic retinopathy. Below is a detailed overview of the criteria used for diagnosis.

Understanding Diabetes Mellitus and Diabetic Retinopathy

Diabetes Mellitus

Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The ICD-10 code E08 specifically denotes diabetes that is secondary to an underlying condition, which could include various diseases or conditions that affect insulin production or action.

Diabetic Retinopathy

Diabetic retinopathy is a common complication of diabetes that affects the eyes. It is classified into two main types:
- Nonproliferative Diabetic Retinopathy (NPDR): This is the early stage of diabetic retinopathy, where the blood vessels in the retina are damaged but do not grow abnormally.
- Proliferative Diabetic Retinopathy (PDR): This is a more advanced stage where new blood vessels grow in the retina, which can lead to severe vision loss.

Diagnostic Criteria for E08.33

1. Diagnosis of Diabetes Mellitus

To diagnose diabetes mellitus, healthcare providers typically use the following criteria:
- Fasting Plasma Glucose (FPG): A level of 126 mg/dL (7.0 mmol/L) or higher.
- Oral Glucose Tolerance Test (OGTT): A 2-hour plasma glucose level of 200 mg/dL (11.1 mmol/L) or higher.
- A1C Test: A hemoglobin A1C level of 6.5% or higher.
- Random Plasma Glucose: A level of 200 mg/dL (11.1 mmol/L) or higher in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis.

2. Identification of Underlying Condition

For the diagnosis to fall under E08, there must be an identifiable underlying condition contributing to the diabetes. This could include:
- Pancreatic diseases (e.g., pancreatitis, pancreatic cancer)
- Hormonal disorders (e.g., Cushing's syndrome, acromegaly)
- Genetic syndromes (e.g., MODY - Maturity Onset Diabetes of the Young)

3. Assessment of Diabetic Retinopathy

The classification of diabetic retinopathy is based on a comprehensive eye examination, which may include:
- Fundoscopy: A detailed examination of the retina using an ophthalmoscope.
- Optical Coherence Tomography (OCT): Imaging that provides cross-sectional pictures of the retina.
- Fluorescein Angiography: A procedure that uses a special dye to visualize blood flow in the retina.

For moderate nonproliferative diabetic retinopathy, the following findings are typically observed:
- Microaneurysms: Small bulges in the blood vessels of the retina.
- Retinal Hemorrhages: Small areas of bleeding in the retina.
- Exudates: Lipid deposits that appear as yellow-white spots on the retina.

4. Clinical Symptoms

Patients may present with symptoms such as:
- Blurred vision
- Difficulty seeing at night
- Fluctuating vision

Conclusion

The diagnosis of ICD-10 code E08.33 requires a comprehensive evaluation that includes confirming the presence of diabetes mellitus due to an underlying condition, assessing the severity of diabetic retinopathy, and identifying specific clinical findings. Proper diagnosis is crucial for effective management and treatment of both diabetes and its ocular complications, ensuring that patients receive appropriate care to prevent further deterioration of their health.

Treatment Guidelines

Diabetes mellitus due to an underlying condition, classified under ICD-10 code E08.33, is a complex condition that can lead to various complications, including diabetic retinopathy. Moderate nonproliferative diabetic retinopathy (NPDR) is characterized by the presence of microaneurysms, retinal hemorrhages, and exudates, but without the growth of new blood vessels, which is a hallmark of proliferative diabetic retinopathy. The management of this condition involves a multifaceted approach that includes glycemic control, regular monitoring, and specific treatments aimed at preventing progression of retinopathy.

Standard Treatment Approaches

1. Glycemic Control

Maintaining optimal blood glucose levels is crucial in managing diabetes and preventing complications such as diabetic retinopathy. The following strategies are commonly employed:

  • Dietary Management: A balanced diet low in simple sugars and high in fiber can help regulate blood sugar levels. Patients are often advised to work with a dietitian to create a personalized meal plan.
  • Physical Activity: Regular exercise can improve insulin sensitivity and help control blood glucose levels. The American Diabetes Association recommends at least 150 minutes of moderate-intensity aerobic activity per week[1].
  • Medications: Depending on the type of diabetes, medications such as metformin, insulin, or other antidiabetic agents may be prescribed to achieve target glycemic levels[2].

2. Regular Eye Examinations

Patients with diabetes should undergo comprehensive eye examinations at least once a year. These exams are essential for early detection and monitoring of diabetic retinopathy. The frequency may increase based on the severity of the retinopathy and the patient's overall health status[3].

3. Treatment of Diabetic Retinopathy

For moderate NPDR, the following treatment options may be considered:

  • Laser Therapy: While laser photocoagulation is more commonly used for proliferative diabetic retinopathy, it may be indicated in certain cases of NPDR to prevent progression. This treatment involves using a laser to create small burns in the retina, which can help reduce the risk of vision loss[4].
  • Anti-VEGF Injections: In some cases, intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents may be used to treat diabetic macular edema, a potential complication of NPDR. These injections can help reduce fluid leakage and improve vision[5].
  • Corticosteroids: Intravitreal corticosteroids may also be considered for managing diabetic macular edema, particularly in patients who do not respond to anti-VEGF therapy[6].

4. Management of Comorbid Conditions

Patients with diabetes often have other health issues, such as hypertension and hyperlipidemia, which can exacerbate diabetic retinopathy. Therefore, managing these conditions is essential:

  • Blood Pressure Control: Maintaining blood pressure within target ranges can significantly reduce the risk of diabetic retinopathy progression. The recommended target is usually less than 140/90 mmHg[7].
  • Lipid Management: Statins and other lipid-lowering agents may be prescribed to manage dyslipidemia, which is common in diabetic patients and can contribute to vascular complications[8].

5. Patient Education and Support

Educating patients about their condition, the importance of adherence to treatment, and lifestyle modifications is vital. Support groups and diabetes education programs can provide valuable resources and encouragement for patients managing diabetes and its complications[9].

Conclusion

The management of diabetes mellitus due to an underlying condition with moderate nonproliferative diabetic retinopathy requires a comprehensive approach that emphasizes glycemic control, regular monitoring, and targeted treatments for retinopathy. By addressing both the diabetes and its ocular complications, healthcare providers can help prevent progression and preserve vision. Regular follow-ups and patient education play critical roles in ensuring effective management and improving patient outcomes.

Related Information

Description

  • Diabetes mellitus due to an underlying condition
  • Moderate nonproliferative diabetic retinopathy
  • Microaneurysms in retinal blood vessels
  • Retinal hemorrhages and exudates present
  • Tight glycemic control is essential
  • Regular eye exams for monitoring
  • Treatment options: laser therapy or injections

Clinical Information

  • Diabetes mellitus due to underlying conditions
  • Hyperglycemia caused by insulin deficiency
  • Moderate nonproliferative diabetic retinopathy
  • Microaneurysms and hemorrhages in the retina
  • Exudates without neovascularization
  • Polyuria, polydipsia, and polyphagia symptoms
  • Blurred vision due to fluctuating blood glucose levels
  • Visual disturbances and scotomas in NPDR patients
  • Difficulty with color vision and increased risk of blindness
  • Typically affects middle-aged or older adults
  • Both males and females are affected
  • Underlying conditions increase risk of diabetes mellitus
  • Poor glycemic control exacerbates retinopathy
  • Hypertension and dyslipidemia worsen retinopathy risk

Approximate Synonyms

  • Diabetes Mellitus Secondary to Other Conditions
  • Diabetes Due to Underlying Disease
  • Moderate Nonproliferative Diabetic Retinopathy
  • E08.33 Diabetes with Moderate Nonproliferative Retinopathy
  • Nonproliferative Diabetic Retinopathy (NPDR)
  • Secondary Diabetes

Diagnostic Criteria

  • Fasting Plasma Glucose level ≥126 mg/dL (7.0 mmol/L)
  • Oral Glucose Tolerance Test 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L)
  • A1C Test hemoglobin A1C ≥6.5%
  • Random Plasma Glucose ≥200 mg/dL (11.1 mmol/L) with classic symptoms
  • Identifiable underlying condition such as pancreatic disease, hormonal disorder or genetic syndrome
  • Microaneurysms in retinal blood vessels
  • Retinal hemorrhages and exudates on retina
  • Blurred vision, difficulty seeing at night, fluctuating vision

Treatment Guidelines

  • Maintain optimal blood glucose levels
  • Dietary management with balanced diet low in simple sugars high in fiber
  • Regular physical activity for at least 150 minutes per week
  • Medications such as metformin or insulin to control glycemic levels
  • Regular eye examinations at least once a year
  • Laser therapy to prevent progression of NPDR
  • Anti-VEGF injections for diabetic macular edema
  • Corticosteroids for managing diabetic macular edema
  • Blood pressure control with target less than 140/90 mmHg
  • Lipid management with statins or other lipid-lowering agents

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.